Aclaris Therapeutics Stock Price History
| ACRS Stock | USD 2.48 0.09 3.77% |
Below is the normalized historical share price chart for Aclaris Therapeutics extending back to October 07, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Aclaris Therapeutics stands at 2.48, as last reported on the 1st of February, with the highest price reaching 2.60 and the lowest price hitting 2.36 during the day.
If you're considering investing in Aclaris Stock, it is important to understand the factors that can impact its price. Aclaris Therapeutics appears to be extremely dangerous, given 3 months investment horizon. Aclaris Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0632, which signifies that the company had a 0.0632 % return per unit of risk over the last 3 months. By analyzing Aclaris Therapeutics' technical indicators, you can evaluate if the expected return of 0.66% is justified by implied risk. Please makes use of Aclaris Therapeutics' Risk Adjusted Performance of 0.0921, downside deviation of 6.01, and Mean Deviation of 5.62 to double-check if our risk estimates are consistent with your expectations.
At this time, Aclaris Therapeutics' Common Stock Shares Outstanding is comparatively stable compared to the past year. Other Stockholder Equity is likely to gain to about 1.1 B in 2025, whereas Liabilities And Stockholders Equity is likely to drop slightly above 169.3 M in 2025. . At this time, Aclaris Therapeutics' Price Book Value Ratio is comparatively stable compared to the past year. Price Earnings To Growth Ratio is likely to gain to 0.12 in 2025, whereas Price Earnings Ratio is likely to drop (0.78) in 2025. Aclaris Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 7th of October 2015 | 200 Day MA 1.7355 | 50 Day MA 3.0592 | Beta 0.116 |
Aclaris |
Sharpe Ratio = 0.0632
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ACRS | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 10.39 actual daily | 92 92% of assets are less volatile |
Expected Return
| 0.66 actual daily | 13 87% of assets have higher returns |
Risk-Adjusted Return
| 0.06 actual daily | 4 96% of assets perform better |
Based on monthly moving average Aclaris Therapeutics is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Aclaris Therapeutics by adding it to a well-diversified portfolio.
Price Book 1.9652 | Enterprise Value Ebitda 0.2785 | Price Sales 9.8012 | Shares Float 55.3 M | Wall Street Target Price 10 |
Aclaris Therapeutics Stock Price History Chart
There are several ways to analyze Aclaris Stock price data. The simplest method is using a basic Aclaris candlestick price chart, which shows Aclaris Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | November 19, 2024 | 4.59 |
| Lowest Price | November 15, 2024 | 2.05 |
Aclaris Therapeutics February 1, 2025 Stock Price Synopsis
Various analyses of Aclaris Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Aclaris Stock. It can be used to describe the percentage change in the price of Aclaris Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Aclaris Stock.| Aclaris Therapeutics Price Daily Balance Of Power | 0.37 | |
| Aclaris Therapeutics Price Rate Of Daily Change | 1.04 | |
| Aclaris Therapeutics Price Action Indicator | 0.04 |
Aclaris Therapeutics February 1, 2025 Stock Price Analysis
Aclaris Stock Price History Data
The price series of Aclaris Therapeutics for the period between Sun, Nov 3, 2024 and Sat, Feb 1, 2025 has a statistical range of 2.98 with a coefficient of variation of 24.8. The prices are distributed with arithmetic mean of 2.84. The median price for the last 90 days is 2.6.| Open | High | Low | Close | Volume | ||
02/01/2025 | 2.50 | 2.60 | 2.36 | 2.48 | ||
| 01/31/2025 | 2.50 | 2.60 | 2.36 | 2.48 | 2,883,450 | |
| 01/30/2025 | 2.37 | 2.42 | 2.34 | 2.39 | 304,602 | |
| 01/29/2025 | 2.40 | 2.41 | 2.28 | 2.36 | 496,686 | |
| 01/28/2025 | 2.45 | 2.47 | 2.33 | 2.39 | 636,551 | |
| 01/27/2025 | 2.47 | 2.54 | 2.39 | 2.45 | 510,235 | |
| 01/24/2025 | 2.58 | 2.58 | 2.48 | 2.51 | 523,615 | |
| 01/23/2025 | 2.56 | 2.58 | 2.49 | 2.55 | 694,865 | |
| 01/22/2025 | 2.61 | 2.61 | 2.51 | 2.60 | 804,029 | |
| 01/21/2025 | 2.61 | 2.64 | 2.48 | 2.60 | 837,779 | |
| 01/17/2025 | 2.54 | 2.59 | 2.46 | 2.57 | 506,730 | |
| 01/16/2025 | 2.49 | 2.53 | 2.44 | 2.51 | 378,510 | |
| 01/15/2025 | 2.56 | 2.57 | 2.42 | 2.51 | 516,113 | |
| 01/14/2025 | 2.50 | 2.50 | 2.31 | 2.50 | 2,692,905 | |
| 01/13/2025 | 2.46 | 2.49 | 2.38 | 2.48 | 2,164,600 | |
| 01/10/2025 | 2.43 | 2.47 | 2.32 | 2.47 | 1,661,360 | |
| 01/08/2025 | 2.46 | 2.51 | 2.40 | 2.46 | 635,036 | |
| 01/07/2025 | 2.51 | 2.60 | 2.43 | 2.50 | 531,348 | |
| 01/06/2025 | 2.63 | 2.65 | 2.45 | 2.53 | 843,854 | |
| 01/03/2025 | 2.49 | 2.80 | 2.49 | 2.60 | 1,045,722 | |
| 01/02/2025 | 2.50 | 2.62 | 2.48 | 2.48 | 501,502 | |
| 12/31/2024 | 2.63 | 2.65 | 2.35 | 2.48 | 909,671 | |
| 12/30/2024 | 2.68 | 2.74 | 2.48 | 2.48 | 826,004 | |
| 12/27/2024 | 2.96 | 2.97 | 2.71 | 2.73 | 552,285 | |
| 12/26/2024 | 2.91 | 3.02 | 2.80 | 2.92 | 761,195 | |
| 12/24/2024 | 2.96 | 2.97 | 2.84 | 2.90 | 499,772 | |
| 12/23/2024 | 2.99 | 3.12 | 2.84 | 2.89 | 1,803,555 | |
| 12/20/2024 | 2.74 | 2.90 | 2.71 | 2.72 | 1,158,170 | |
| 12/19/2024 | 3.09 | 3.11 | 2.76 | 2.77 | 660,704 | |
| 12/18/2024 | 3.22 | 3.25 | 2.92 | 3.08 | 1,400,149 | |
| 12/17/2024 | 3.00 | 3.29 | 2.91 | 3.26 | 1,460,136 | |
| 12/16/2024 | 3.20 | 3.27 | 2.99 | 3.02 | 1,049,314 | |
| 12/13/2024 | 3.16 | 3.35 | 3.14 | 3.22 | 858,513 | |
| 12/12/2024 | 3.53 | 3.57 | 3.26 | 3.27 | 683,133 | |
| 12/11/2024 | 3.64 | 3.66 | 3.38 | 3.54 | 829,372 | |
| 12/10/2024 | 3.93 | 4.00 | 3.61 | 3.63 | 695,607 | |
| 12/09/2024 | 3.97 | 4.03 | 3.77 | 3.91 | 1,065,989 | |
| 12/06/2024 | 3.90 | 3.99 | 3.76 | 3.94 | 772,598 | |
| 12/05/2024 | 3.71 | 3.97 | 3.71 | 3.81 | 710,504 | |
| 12/04/2024 | 3.88 | 4.05 | 3.75 | 3.76 | 768,019 | |
| 12/03/2024 | 3.93 | 3.96 | 3.71 | 3.85 | 1,292,167 | |
| 12/02/2024 | 4.05 | 4.17 | 3.81 | 3.96 | 1,053,534 | |
| 11/29/2024 | 3.86 | 4.24 | 3.85 | 4.07 | 1,007,982 | |
| 11/27/2024 | 3.64 | 3.94 | 3.64 | 3.82 | 846,547 | |
| 11/26/2024 | 3.93 | 4.15 | 3.63 | 3.63 | 1,966,198 | |
| 11/25/2024 | 4.11 | 4.23 | 3.86 | 3.99 | 1,686,930 | |
| 11/22/2024 | 4.28 | 4.44 | 3.80 | 3.80 | 2,974,980 | |
| 11/21/2024 | 4.25 | 4.55 | 4.07 | 4.32 | 2,962,962 | |
| 11/20/2024 | 4.44 | 4.44 | 3.67 | 3.96 | 5,850,128 | |
| 11/19/2024 | 3.71 | 5.17 | 3.69 | 4.59 | 56,341,039 | |
| 11/18/2024 | 2.43 | 3.54 | 2.29 | 3.14 | 30,619,043 | |
| 11/15/2024 | 2.20 | 2.29 | 2.03 | 2.05 | 736,031 | |
| 11/14/2024 | 2.40 | 2.47 | 2.18 | 2.18 | 1,158,732 | |
| 11/13/2024 | 2.55 | 2.72 | 2.43 | 2.44 | 1,414,291 | |
| 11/12/2024 | 2.48 | 2.59 | 2.34 | 2.56 | 628,495 | |
| 11/11/2024 | 2.67 | 2.68 | 2.09 | 2.63 | 1,759,215 | |
| 11/08/2024 | 2.48 | 2.67 | 2.48 | 2.64 | 1,002,575 | |
| 11/07/2024 | 2.27 | 2.55 | 2.26 | 2.45 | 1,006,004 | |
| 11/06/2024 | 2.24 | 2.35 | 2.19 | 2.26 | 578,620 | |
| 11/05/2024 | 2.18 | 2.31 | 2.15 | 2.22 | 1,215,312 | |
| 11/04/2024 | 2.09 | 2.23 | 2.04 | 2.17 | 1,803,472 |
About Aclaris Therapeutics Stock history
Aclaris Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Aclaris is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Aclaris Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Aclaris Therapeutics stock prices may prove useful in developing a viable investing in Aclaris Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 80.3 M | 84.3 M | |
| Net Loss | -78.2 M | -82.1 M |
Aclaris Therapeutics Quarterly Net Working Capital |
|
Aclaris Therapeutics Stock Technical Analysis
Aclaris Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Content Syndication Now
Content SyndicationQuickly integrate customizable finance content to your own investment portal |
| All Next | Launch Module |
Aclaris Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Aclaris Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Aclaris Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Aclaris to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0921 | |||
| Jensen Alpha | 1.0 | |||
| Total Risk Alpha | 0.1639 | |||
| Sortino Ratio | 0.1549 | |||
| Treynor Ratio | (15.63) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Aclaris Stock Analysis
When running Aclaris Therapeutics' price analysis, check to measure Aclaris Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aclaris Therapeutics is operating at the current time. Most of Aclaris Therapeutics' value examination focuses on studying past and present price action to predict the probability of Aclaris Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aclaris Therapeutics' price. Additionally, you may evaluate how the addition of Aclaris Therapeutics to your portfolios can decrease your overall portfolio volatility.